These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 7783337
21. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome. Lopez LR, Dier KJ, Lopez D, Merrill JT, Fink CA. Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252 [Abstract] [Full Text] [Related]
22. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome. Cucnik S, Kveder T, Krizaj I, Rozman B, Bozic B. Ann Rheum Dis; 2004 Nov; 63(11):1478-82. PubMed ID: 15479898 [Abstract] [Full Text] [Related]
23. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies. Horbach DA, van Oort E, Donders RC, Derksen RH, de Groot PG. Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011 [Abstract] [Full Text] [Related]
24. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. Swadzba J, De Clerck LS, Stevens WJ, Bridts CH, van Cotthem KA, Musial J, Jankowski M, Szczeklik A. J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792 [Abstract] [Full Text] [Related]
25. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus. Sanfilippo SS, Khamashta MA, Atsumi T, Amengual O, Bertolaccini ML, D'Cruz D, Amft N, Swana GT, Hughes GR. J Rheumatol; 1998 Nov; 25(11):2131-4. PubMed ID: 9818654 [Abstract] [Full Text] [Related]
26. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome. Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R. J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014 [Abstract] [Full Text] [Related]
27. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus. Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E. Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489 [Abstract] [Full Text] [Related]
28. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. Somers E, Magder LS, Petri M. J Rheumatol; 2002 Dec; 29(12):2531-6. PubMed ID: 12465147 [Abstract] [Full Text] [Related]
29. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome. Fanopoulos D, Teodorescu MR, Varga J, Teodorescu M. J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168 [Abstract] [Full Text] [Related]
30. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus. Tarr T, Lakos G, Bhattoa HP, Szegedi G, Shoenfeld Y, Kiss E. Lupus; 2007 Apr; 16(5):324-8. PubMed ID: 17576733 [Abstract] [Full Text] [Related]
32. [Association between antiphospholipid antibodies and arterial or venous thrombosis/thrombocytopenia]. Nojima J, Suehisa E, Kuratsune H, Amino N. Rinsho Byori; 1998 Dec; 46(12):1181-7. PubMed ID: 9916502 [Abstract] [Full Text] [Related]
33. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus. Koskenmies S, Vaarala O, Widen E, Kere J, Palosuo T, Julkunen H. Scand J Rheumatol; 2004 Dec; 33(4):246-52. PubMed ID: 15370721 [Abstract] [Full Text] [Related]
35. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome. Salazar-Páramo M, Jara LJ, Ramos A, Barile L, Machado G, García-De La Torre I. Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952 [Abstract] [Full Text] [Related]
36. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome. Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE. Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539 [Abstract] [Full Text] [Related]
37. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus. Martinez-Berriotxoa A, Ruiz-Irastorza G, Egurbide MV, Garmendia M, Gabriel Erdozain J, Villar I, Aguirre C. Lupus; 2007 Mar; 16(10):810-6. PubMed ID: 17895304 [Abstract] [Full Text] [Related]
38. Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. Satoh A, Suzuki K, Takayama E, Kojima K, Hidaka T, Kawakami M, Matsumoto I, Ohsuzu F. J Rheumatol; 1999 Aug; 26(8):1715-20. PubMed ID: 10451067 [Abstract] [Full Text] [Related]
39. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome]. Soltész P, Veres K, Kiss E, Lakos G, Sonkoly I, Muszbek L, Szegedi G. Orv Hetil; 2000 Dec 24; 141(52):2821-5. PubMed ID: 11202118 [Abstract] [Full Text] [Related]
40. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis. Musial J, Swadzba J, Motyl A, Iwaniec T. J Rheumatol; 2003 Apr 24; 30(4):723-30. PubMed ID: 12672190 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]